Government News

IPA asks AIIMS not to violate recruitment rules of pharmacists

  • Posted on: 1 May 2019
  • By: PharmaTutor News

Indian Pharmacists Association (IPA) strictly opposes use of the post name Dispensing Attendant instead of Pharmacist for recent recruitment advertisement by AIIMS Rishikesh. As per IPA, the advertisement No. 2019/153 by AIIMS Rishikesh is violating Pharmacy Act and Drugs and Cosmetic rules.

Indian have poor access to anticancer drugs : Study

  • Posted on: 26 April 2019
  • By: PharmaTutor News

Limited access to essential medicines for treating chronic diseases is a major challenge in low and middle-income countries. Although India is the largest manufacturer of generic medicines, there is a paucity of information on availability, price and affordability of essential anti-cancer medicines used for treating childhood cancers.

Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis: EMA

  • Posted on: 25 March 2019
  • By: Shalini.Sharma

EMA is advising healthcare professionals and patients not to exceed the recommended dose of Xeljanz (tofacitinib) when treating rheumatoid arthritis. The advice follows early results from an ongoing study (study A3921133) in patients with rheumatoid arthritis which showed an increased risk of blood clots in the lungs and death when the normal dose of 5 mg twice daily was doubled.

Health Ministry takes stock of the public health measures for controlling West Nile Virus

  • Posted on: 15 March 2019
  • By: Shalini.Sharma

A section of the media has reported that a seven year old boy from Malappuram District of Kerala is suffering from a West Nile Virus (WNV), a mosquito-borne disease, mostly reported in the continental United States. Union Minister of Health and Family Welfare is closely monitoring the situation and has spoken to the State Health Minister of Kerala in this regard. He has directed for all support to be extended to Kerala in its prevention and management.

Significant Reduction in Cancer Drug Prices due to Trade Margin Capping

  • Posted on: 1 March 2019
  • By: Shalini.Sharma

Cancer is one of the leading causes of adult illness and death due to chronic non-communicable diseases in India.   India is witnessing a steady rise in cancer incidence.  The number of incident-cases has risen from 8 lakh in 2004 to an estimated 15 lakh (annually) by 2018.  Even with nearly two third of patients eventually dying of this disease, an estimated 22.5 lakh patients are currently living with cancer in India.

Countries are spending more on health, but people are still paying too much out of their own pockets : WHO

  • Posted on: 22 February 2019
  • By: Shalini.Sharma

Health spending is made up of government expenditure, out-of-pocket payments (people paying for their own care), and sources such as voluntary health insurance, employer-provided health programmes, and activities by non-governmental organizations.